RDC 327/2019 - Medicinal use of Cannabis-based products in Brazil

The Brazilian Regulatory Authority (ANVISA) published the regulation RDC 327/2019, determining the technical requirements that technical dossiers for Cannabis-based Products should contain for future analysis by the Agency. This new legislation should be in force in 90 days from the date of publication in the Brazilian Official Gazette. This approval by ANVISA creates a class of products, i.e. those based on Cannabis spp. Read more...

Latini Group


Redes sociais